Arginine supplements to help prevent pregnancy complications
Treatments studied
Part of Genetic & congenital, Infections, Women’s health & pregnancy clinical trials.
This study tests whether taking an arginine-based supplement during pregnancy can help lower the risk of bad pregnancy outcomes. You may be eligible if you are pregnant in the early-to-mid period and meet safety and location requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and between 16 and 40 years old
- You are no more than 24 weeks pregnant (confirmed by ultrasound)
- You have one baby (a singleton pregnancy), not twins or more
- You live in the study area and can attend all study visits
- You plan to deliver at a study clinic or hospital
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a daily supplement for healthy pregnant women in their second trimester (weeks 14-19). It aims to see if the product is safe and well-tolerated during pregnancy.
This study looks at how much leucine (a building block of protein) pregnant women need in early versus late pregnancy. It could help improve nutrition advice for expecting mothers.
This trial tests if a nitrate supplement (similar to beetroot) can help control chronic high blood pressure in early pregnancy. It is for women already taking methyldopa and enrolled before 16 weeks.
This trial is checking if certain proteins in your blood (called placental growth factor and nucleosomes) during early pregnancy can help predict problems like preeclampsia or preterm birth. If you join, you'll give a blood sample during your regular NIPT test, and researchers will follow your pregnancy to see how it goes.
This study looks at whether giving an amino-acid supplement called arginine to newborns after major bowel surgery can improve the baby’s immune response. It may help doctors understand how to support recovery after conditions like necrotizing enterocolitis or certain birth defects.
This Phase 2 trial tests whether replacing the body’s arginine (an amino acid) can improve outcomes for children and young adults hospitalized with COVID-19. It may help the immune response, but you must meet several safety criteria to join.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.